提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
69
天
Four decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)– Part I: Product Quality
作者Mehul Mehta
作者单位1. Division of Neuropsychiatric Products, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, USA
78
天
Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence
作者Mehul Mehta
作者单位1. Division of Neuropsychiatric Products, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, USA
131
天
Engineering and Characterisation of 3D-Printed Timolol Maleate Implants for Long-Acting Glaucoma Treatment
作者Febri Annuryanti; Masoud Adhami; Eneko Larrañeta; Lalitkumar Vora; Thakur Raghu Raj Singh
作者单位1. Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia; 2. McClay Research Centre, Medical Biology Centre, School of Pharmacy, Queen’s University Belfast, Belfast, UK
74
天
Verification of a Physiologically-based Pharmacokinetic Model for Predicting CYP3A4-mediated Simvastatin and Simvastatin Acid Drug-drug Interactions
作者Bridget L. Morse; Bing Han; Jeffrey J. Alberts; Maria M. Posada; Gemma L. Dickinson; Stephen D. Hall
作者单位1. Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, USA; 2. Clinical & Quantitative Pharmacology, Vertex Pharmaceuticals, Boston, USA
118
天
Exploring a Persistent Terbinafine – CYP2D6 Interaction Using Physiologically – Based Pharmacokinetic Modeling
作者Devendra Pade; Jan Wahlstrom
作者单位1. Pharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, USA; 2. Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, USA
128
天
Immunogenicity Assays Used in Support of Marketing Applications of Oligonucleotide Therapeutics
作者Cecilia Arfvidsson; Lin-Zhi Chen; Susovan Mohapatra; Kamalika Mukherjee; Pallab Pradhan; Gnana Oli Rajaraman; Arkadeep Sinha; Christopher C. Stebbins; An Zhao; Zhandong Don Zhong; Robert J. Kubiak
作者单位1. Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, Gothenborg, Sweden; 2. Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA; 3. Stoke Therapeutics, Boston, USA; 4. Regeneron Pharmaceuticals, Tarrytown, USA; 5. AstraZeneca, Gaithersburg, USA; 6. AiCuris Anti-Infective Cures AG, Wuppertal, Germany; 7. Upstream Bio, Waltham, USA; 8. Immunologix Laboratories, Tampa, USA; 9. Denali Therapeutics, South San Francisco, USA; 10. Third Arc Bio, Lower Gwynedd, USA
136
天
Dissolution Enhancement by Binding Agents: A Potential Shortcut to Improving Bioavailability?
作者Maja Chronowska; Jennifer Dressman
作者单位1. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany; 2. Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany; 3. Heraclitus Advisors Pty. Ltd., Melbourne, Australia
139
天
In Vitro Release Testing for Long Acting Injectables – a Workshop Summary Report
作者Talia Flanagan; Diane Burgess; Marieta Duvnjak; Nikoletta Fotaki; Kate Harris; Krutika Meena Harish Jain; Dawen Kou; Adam McCartan; Heather Mead; Johanna Milsmann; Randy Mrsny; Vasiliki Paraskevopoulou; Sharadvi Thati; Marta Venczel; David Curran
作者单位1. UCB Pharma SA, CMC Development Sciences, Braine L’Alleud, Belgium; 2. University of Connecticut, Department of Pharmaceutical Sciences, Storrs, USA; 3. Novartis, Analytical Research & Development, Novartis Pharma AG, Basel, Switzerland; 4. University of Bath, Department of Life Sciences, Claverton Down, UK; 5. AstraZeneca, Global Product Development, Pharmaceutical Technology & Development, Operations, Macclesfield, UK; 6. Gilead Sciences, Analytical Development and Operations, Foster City, USA; 7. Genentech, Synthetic Molecule Pharmaceutical Sciences, South San Francisco, USA; 8. Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Product Development NCE, Biberach, Germany; 9. Bristol Myers Squibb, New Brunswick, USA; 10. Sanofi, Global CMC Development, Sanofi-Aventis Deutschland GmbH, Frankfurt/Main, Germany; 11. GSK, Analytical Development, Collegeville, USA
178
天
Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy
作者Ching-Ha Lai; Susan C. Irvin; Laura I Salazar-Fontana; Christine Grimaldi; Boris Gorovits; Yuanxin Xu; Michael A. Partridge
作者单位1. Bioanalytical Sciences, Regeneron Pharmaceuticals, Inc., Tarrytown, United States of America; 2. LAIZ Regulatory Science Consulting Sàrl, Lausanne, Switzerland; 3. Intellia Therapeutics, Cambridge, United States of America
151
天
Hand-Held Raman Spectroscopy for Paracetamol Assay in Solution for Infusion: Expanding the Capabilities of Process Analytical Technologies
作者João Henriques; Thomas De Beer; Catarina Cardoso; Vera Moura; Carla Vitorino
作者单位1. Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Coimbra, Portugal; 2. Laboratórios Basi, Parque Industrial Manuel Lourenço Ferreira, Mortágua, Portugal; 3. Basinnov Life Sciences, Unipessoal LDA, Lisbon, Portugal; 4. Laboratory of Pharmaceutical Process Analytical Technology, Department of Analytics, Ghent University, Ghent, Belgium; 5. Coimbra Chemistry Centre, Institute of Molecular Sciences – IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天